These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 33888872)

  • 21. Imaging of Reactive Astrogliosis by Positron Emission Tomography.
    Harada R; Furumoto S; Kudo Y; Yanai K; Villemagne VL; Okamura N
    Front Neurosci; 2022; 16():807435. PubMed ID: 35210989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Astrocytosis precedes amyloid plaque deposition in Alzheimer APPswe transgenic mouse brain: a correlative positron emission tomography and in vitro imaging study.
    Rodriguez-Vieitez E; Ni R; Gulyás B; Tóth M; Häggkvist J; Halldin C; Voytenko L; Marutle A; Nordberg A
    Eur J Nucl Med Mol Imaging; 2015 Jun; 42(7):1119-32. PubMed ID: 25893384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ³H-deprenyl and ³H-PIB autoradiography show different laminar distributions of astroglia and fibrillar β-amyloid in Alzheimer brain.
    Marutle A; Gillberg PG; Bergfors A; Yu W; Ni R; Nennesmo I; Voytenko L; Nordberg A
    J Neuroinflammation; 2013 Jul; 10():90. PubMed ID: 23880036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cryptic Sites in Tau Fibrils Explain the Preferential Binding of the AV-1451 PET Tracer toward Alzheimer's Tauopathy.
    Murugan NA; Nordberg A; Ågren H
    ACS Chem Neurosci; 2021 Jul; 12(13):2437-2447. PubMed ID: 34152739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Candidate PET Radioligand Development for Neurofibrillary Tangles: Two Distinct Radioligand Binding Sites Identified in Postmortem Alzheimer's Disease Brain.
    Cai L; Qu B; Hurtle BT; Dadiboyena S; Diaz-Arrastia R; Pike VW
    ACS Chem Neurosci; 2016 Jul; 7(7):897-911. PubMed ID: 27171905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distribution of [(3)H]BU224, a selective imidazoline I(2) binding site ligand, in rat brain.
    Robinson ES; Tyacke RJ; Nutt DJ; Hudson AL
    Eur J Pharmacol; 2002 Aug; 450(1):55-60. PubMed ID: 12176109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: a multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG.
    Carter SF; Schöll M; Almkvist O; Wall A; Engler H; Långström B; Nordberg A
    J Nucl Med; 2012 Jan; 53(1):37-46. PubMed ID: 22213821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization and first human investigation of FIBT, a novel fluorinated Aβ plaque neuroimaging PET radioligand.
    Yousefi BH; Manook A; Grimmer T; Arzberger T; von Reutern B; Henriksen G; Drzezga A; Förster S; Schwaiger M; Wester HJ
    ACS Chem Neurosci; 2015 Mar; 6(3):428-37. PubMed ID: 25482310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Key Mediator and Imaging Target in Alzheimer's Disease: Unlocking the Role of Reactive Astrogliosis Through MAOB.
    Nam MH; Na H; Justin Lee C; Yun M
    Nucl Med Mol Imaging; 2024 Jun; 58(4):177-184. PubMed ID: 38932762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer's disease.
    Kadir A; Marutle A; Gonzalez D; Schöll M; Almkvist O; Mousavi M; Mustafiz T; Darreh-Shori T; Nennesmo I; Nordberg A
    Brain; 2011 Jan; 134(Pt 1):301-17. PubMed ID: 21149866
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preclinical and clinical study on [
    Xu M; Guo J; Gu J; Zhang L; Liu Z; Ding L; Fu H; Ma Y; Liang S; Wang H
    Eur J Nucl Med Mol Imaging; 2022 Jan; 49(2):652-663. PubMed ID: 34292345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regional binding of tau and amyloid PET tracers in Down syndrome autopsy brain tissue.
    Lemoine L; Ledreux A; Mufson EJ; Perez SE; Simic G; Doran E; Lott I; Carroll S; Bharani K; Thomas S; Gilmore A; Hamlett ED; Nordberg A; Granholm AC
    Mol Neurodegener; 2020 Nov; 15(1):68. PubMed ID: 33222700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amyloid, tau, and astrocyte pathology in autosomal-dominant Alzheimer's disease variants: AβPParc and PSEN1DE9.
    Lemoine L; Gillberg PG; Bogdanovic N; Nennesmo I; Saint-Aubert L; Viitanen M; Graff C; Ingelsson M; Nordberg A
    Mol Psychiatry; 2021 Oct; 26(10):5609-5619. PubMed ID: 32581318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Astroglial Responses to Amyloid-Beta Progression in a Mouse Model of Alzheimer's Disease.
    Olsen M; Aguilar X; Sehlin D; Fang XT; Antoni G; Erlandsson A; Syvänen S
    Mol Imaging Biol; 2018 Aug; 20(4):605-614. PubMed ID: 29297157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo evaluation of a new ¹⁸F-labeled PET ligand, [¹⁸F]FEBU, for the imaging of I₂-imidazoline receptors.
    Kawamura K; Shimoda Y; Kumata K; Fujinaga M; Yui J; Yamasaki T; Xie L; Hatori A; Wakizaka H; Kurihara Y; Ogawa M; Nengaki N; Zhang MR
    Nucl Med Biol; 2015 Apr; 42(4):406-12. PubMed ID: 25583220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [In vivo imaging of astrogliosis by PET].
    Harada R; Okamura N
    Nihon Yakurigaku Zasshi; 2023; 158(1):26-29. PubMed ID: 36596483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dissecting the Binding Profile of PET Tracers to Corticobasal Degeneration Tau Fibrils.
    Zhou Y; Li J; Nordberg A; Ågren H
    ACS Chem Neurosci; 2021 Sep; 12(18):3487-3496. PubMed ID: 34464084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Binding of two potential imaging agents targeting amyloid plaques in postmortem brain tissues of patients with Alzheimer's disease.
    Kung MP; Hou C; Zhuang ZP; Skovronsky D; Kung HF
    Brain Res; 2004 Oct; 1025(1-2):98-105. PubMed ID: 15464749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preclinical Evaluation of
    Honer M; Gobbi L; Knust H; Kuwabara H; Muri D; Koerner M; Valentine H; Dannals RF; Wong DF; Borroni E
    J Nucl Med; 2018 Apr; 59(4):675-681. PubMed ID: 28970331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and evaluation of [
    Mukherjee J; Liang C; Patel KK; Lam PQ; Mondal R
    Synapse; 2021 Jan; 75(1):e22183. PubMed ID: 32722889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.